Streetbeat News

Stock Prices

MEDP

Medpace Holdings projects its FY24 GAAP EPS to be between $10.79 and $11.47, surpassing the estimated $10.61. The company anticipates revenues to range from $2.15 billion to $2.2 billion, slightly below the $2.185 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:23 pm

CBNK

Capital Bancorp (NASDAQ:CBNK) reported Q1 earnings of $0.51 per share, surpassing the consensus estimate of $0.50, a 25% decrease from last year's $0.68. Sales reached $40.98M, beating estimates of $40.69M, marking a 1.15% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:23 pm

MEDP

Medpace Holdings (MEDP) reported Q1 2024 earnings of $3.20 per share, surpassing the $2.46 estimate, but its sales of $511M fell short of the $512.585M forecast. This represents a 17.72% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:20 pm

SSD

Simpson Manufacturing Co. (SSD) reported Q1 2024 earnings of $1.77 per share, missing the consensus estimate of $1.92. Quarterly sales were $530.579M, below the estimate of $549.854M, marking a 0.72% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:18 pm

CR

Crane Company has increased its adjusted EPS guidance for FY24 from the range of $4.55-$4.85 to $4.75-$5.05, surpassing the estimated $4.81.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:16 pm

HXL

Hexcel (NYSE:HXL) reported Q1 earnings of $0.43 per share, surpassing the $0.41 estimate, but saw a 14% decrease from last year's $0.50. Sales reached $472.30M, slightly missing the $473.78M estimate but marking a 3.19% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:15 pm

MNTS

Momentus Inc. (NASDAQ:MNTS) received a deficiency notification from Nasdaq for not filing its Form 10-K for the year ended December 31, 2023, on time. The notice does not immediately affect its Nasdaq listing. Momentus has 60 days to file the Form 10-K or submit a compliance plan to Nasdaq. If accepted, Nasdaq may grant up to 180 days to regain compliance. Failure to comply may lead to delisting, but Momentus intends to file the Form 10-K as soon as possible.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:13 pm

APDN

Applied DNA Sciences, Inc. (APDN) announced a 1-for-20 reverse stock split effective April 25, 2024. The split-adjusted trading will start on the same day on the Nasdaq Capital Market under the new CUSIP number 03815U409. This action will reduce the issued and outstanding shares from approximately 17.26 million to about 863,000 shares. Adjustments will be made to outstanding stock options, restricted stock units, and warrants, including exercise or conversion prices. No fractional shares will be issued; instead, they will be rounded up to the nearest whole share.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:12 pm

SAP

SAP shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:12 pm

PHYT

Pyrophyte Acquisition Corp. (PHYT) has received a notice from the NYSE for not filing its Form 10-K on time. This notice is a standard procedure for companies that fail to meet the SEC's filing deadlines. PHYT is required to submit a plan to regain compliance within six months to avoid potential delisting. The company's stock may face volatility as investors react to the news of the delayed filing and the risk of delisting.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 8:10 pm